-+ 0.00%
-+ 0.00%
-+ 0.00%

Aardvark Therapeutics Doses First Patient in Phase 3 HERO Trial for Prader-Willi Syndrome

路透·12/10/2025 21:05:12

登錄查看新聞詳情